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Abstract
The current protocols for generation of induced pluripotent stem (iPS) cells involve genome integrating viral vectors which
may induce tumorgenesis. The aim of this study was to develop and optimize a non-viral method without genetic
manipulation for reprogramming of skeletal myoblasts (SMs) using small molecules.
Methods and Results: SMs from young male Oct3/4-GFP
+ transgenic mouse were treated with DNA methyltransferase
(DNMT) inhibitor, RG108. Two weeks later, GFP
+ colonies of SM derived iPS cells (SiPS) expressing GFP and with
morphological similarity of mouse embryonic stem (ESCs) were formed and propagated in vitro. SiPS were positive for
alkaline phosphatase activity, expressed SSEA1, displayed ES cell specific pluripotency markers and formed teratoma in
nude mice. Optimization of culture conditions for embryoid body (EBs) formation yielded spontaneously contracting EBs
having morphological, molecular, and ultra-structural similarities with cardiomyocytes and expressed early and late cardiac
markers. miR profiling showed abrogation of let-7 family and upregulation of ESCs specific miR-290-295 cluster thus
indicating that SiPS were similar to ESCs in miR profile. Four weeks after transplantation into the immunocompetent mice
model of acute myocardial infarction (n=12 per group), extensive myogenesis was observed in SiPS transplanted hearts as
compared to DMEM controls (n=6 per group). A significant reduction in fibrosis and improvement in global heart function
in the hearts transplanted with SiPS derived cardiac progenitor cells were observed.
Conclusions: Reprogramming of SMs by DNMT inhibitor is a simple, reproducible and efficient technique more likely to
generate transgene integration-free iPS cells. Cardiac progenitors derived from iPS cells propagated extensively in the
infarcted myocardium without tumorgenesis and improved cardiac function.
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Introduction
The introduction of four transcription factors, Oct3/4, Sox2,
Klf4, and c-Myc can successfully reprogram mouse and human
somatic cells into induced pluripotent stem (iPS) cells [1,2].
However the current reprogramming approach requires viral
transduction which hampered the use of iPS due to genetic
variability caused by random integration of multiple pro-viral
copies [3,4]. Several multidisciplinary approaches involving the
use of non integrating adenoviral vectors [5], non-viral plasmid
transfection [6,7] and piggy Bac transposition [8] had been
attempted by various research groups to refine and improve the
iPS cell generation. Given that Oct3/4, Sox2, and Nanog
constitute the core of regulatory loop which is imperative to
determine the pluripotent status of the cells, other studies showed
the dispensable status of cMyc and Klf4 for reprogramming
process [9,4]. However, Oct3/4 apparently cannot be replaced for
pluripotency by other factors. Oct3/4 is a key regulator of mouse
embryogenesis and is expressed in the pluripotent cells of an
embryo and in cell lines derived thereafter [10]. Given the
molecular pathways underlying iPS cell generation, the use of
lesser number of transcription factors combined with small
molecules is being promoted for pluripotency [9,11]. For
epigenetic reprogramming, inhibition of DNMT and histone
deacetylases with small molecules is important to reduce
transcription of silenced genes [12,13]. Therefore, the possibility
to reactivate epigenetically silenced genes has generated consid-
erable interest in the use of DNMT inhibitors. RG108, a DNMT
inhibitor, is a potent small molecule that effectively blocks DNMT
in vitro and does not cause covalent enzyme trapping in human cell
lines [14]. We report here for the first time that mouse skeletal
myoblasts (SMs) can be efficiently reprogrammed into iPS cells
(SiPs) with DNMT inhibitor by induction of a single transcription
factor Oct3/4. These SiPS cells resemble ES cells in their
molecular behavior and differentiation characteristics. We further
report that cardiac progenitors (SiPS-CPs) derived from beating
EBs obtained from SiPS showed remarkable regeneration of
myocardium and formed gap junctions with the resident
cardiomyocytes when transplanted in an infarcted mouse heart.
We also observed a significant attenuation of infarct size expansion
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23667Figure 1. SiPS generation from SMs by single small molecule treatment. (A) The native SMs cells were stained for desmin expression (red
fluorescence) and confirmed by flow cytometry (96%) to show the purity of SMs. The nuclei were stained with DAPI (blue fluorescence). (B) Gene
expression profile of various stemness and myogenic markers in SMs, ES cells and SiPS isolates. RT-PCR analyses showing the endogenous expression
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transplanted animal hearts. Our purely chemical approach is
superior and safest in efficient reprogramming of SMs for
generation of cardiac progenitors.
Materials and Methods
Isolation of mouse SMs
For our animal experiments, we used the Oct4/GFP transgenic
mouse strain (Jackson laboratories, Maine, USA) with GFP-tagged
to the endogenous Oct3/4 gene promoter. For SMs isolation, we
followed the standard protocols routinely used in our laboratory as
described in Text S1.
SiPS generation and maintenance
SMs derived from Oct3/4-GFP mice (at passage 1–2; 1610
5
cells/well of a 6-well dish) were treated overnight with 500 mM
RG108 (Stemgent, CA, USA) in 0.5% DMSO for 5 days. Control
cells were treated with DMSO 0.05% without RG108. At day 6,
the treated cells were passaged on the mouse embryonic fibroblasts
(MEF) coated 10 cm cell culture dishes and observed for the
development of SiPS clones until 3 weeks. The cell growth media
was changed daily. On day 15, appearance of ES cells like GFP
+
clones were observed and counted. The GFP
+ SiPS clones were
mechanically incised, cultured on mouse feeder cells and
expanded individually in ES cell culture medium for use in
further experiments. For induction of pluripotency markers, SiPS
were fixed with 4% paraformaldehyde, permeabilized and stained
with anti-stage specific embryonic antigen-1 (SSEA-1) antibody.
The primary antigen-antibody reaction was detected with goat
anti-mouse Alexa Fluor-568 conjugated secondary antibody (1:
200; Cell Signaling Tech, Danvers, MA). Nuclei were visualized
by 4,69 -diamidino-2-phenylindole (DAPI; Invitrogen, Carlsbad,
CA) staining. The murine SiPS clone ZP1 was expanded on
mitotically inactivated murine embryonic fibroblasts (MEFs;
5610
4cells/cm
2) and maintained as described in Text S1.
Reverse transcription polymerase chain reaction (RT-PCR)
Isolation of total RNA, and their subsequent first-strand cDNA
synthesis, was performed using an RNeasy mini kit (Qiagen,
Valencia, CA) and an Omniscript Reverse Transcription kit
(Qiagen, Valencia, CA) respectively per manufacturer’s instruc-
tions and detailed in Text S1. The primer sequences used are
given in Table S1.
Alkaline phosphatase staining and
immunocytochemistry
Alkaline phosphatase staining was performed using Alkaline
Phosphatase Detection kit (Millipore SCR2004) per manufactur-
er’s instructions. For immunocytochemistry, undifferentiated
colonies of SiPs were immunostained with respective specific
primary antibodies (anti-SSEA1, anti-Oct3/4, anti-Sox2 antibod-
ies, all at 1: 100 dilutions; Cell Signaling, Danvers, USA) as
described in Text S1. Fluorescence signals were observed and
photographed using fluorescence microscope (Olympus, Tokyo,
Japan).
DNA methyltransferase (DNMT) activity assay
Nuclear extracts were isolated using the NE-PER Nuclear and
Cytoplasmic Extraction Kit (Thermo Scientific, IL USA). Total
DNMT activity was determined using an EpiQuik DNA
methyltransferase activity assay kit (Epigentek, Brooklyn, NY)
per manufacturer’s protocol. Enzyme activity for samples and
controls was measured on a microplate reader (Hidex Chameleon,
Finland) at 450 nm and DNMT activity (OD/h/ml) was
calculated according to the formula: (Sample OD2blank OD)/
(sample volume)61000.
Embryoid body formation for spontaneous cardiac
differentiation
SiPS were cultured in ultralow attachment dishes (Corning, NY,
USA) for 3 days in high glucose DMEM supplemented with 15%
FBS, 0.1 mmol/L non-essential amino acids, 1 mmol/L L-
glutamine, 0.1 mmol/L b-mercaptoethanol, and 5 mM Pencil-
lin/Streptomycin. After 3 days in cell suspension, rounded EBs
were formed that were seeded on gelatin-coated dishes and
cultured for 15 days. The contracting EBs on day 5 were
microdissected and dissociated into single cells for further
experiments including immunostaining and RT-PCR.
Ultra-structural studies of EBs derived cardiac progenitors
Ultra-structural studies were performed on SiPS-CP derived
from 5-day beating EBs as described in Text S1 using JEOL
transmission electron microscope.
Teratoma formation and Karyotyping
Teratogenicity of SiPS was assessed in immunodeficient mice
(n=3) as described in Text S1. Karyotyping was determined at
molecular cytogenetic facility of Ohio State University, OH.
MicroRNA microarray Analysis
A total of 4–8 mg RNA sample each was prepared from SMs,
mouse ES cells and SiPs. MicroRNA expression profiling was
performed using a microarray service provider (LC Sciences, TX,
USA) and as described in Text S1.
Experimental animal model of myocardial infarction
All experimental procedures were performed in accordance
with the standard human care guidelines of the ‘‘Guide for the
Care and Use of Laboratory Animals’’ and were approved by the
Institutional Animal Care and Use Committee of University of
Cincinnati (Protocol ID: 06-03-13-03), which conforms to
National Institutes of Health guidelines. Myocardial Infarction
model was induced in young female 8–12 weeks old immuno-
competent C57BL/6J mice [15]. Briefly, the animals were
anesthetized with (ketamine/xylazine 0.05 ml intra-peritonealy).
A midline cervical skin incision was performed for intubation. The
animals were mechanically ventilated with room air supplemented
of myogenic and pluripotency marker genes in SMs and ES cells. SMs showed 3 pluripotency markers (Sox2, Klf4, cMyc) in addition to MyoD and Pax7
in comparison to ES cell expressing all 4 pluripotency markers. RG108 significantly induced Oct3/4 expression in SiPS with simultaneous loss of
myogenic markers MyoD and Pax7 after reprogramming. Densitometric quantization of mRNA expression of Oct3/4, Sox2, Klf4, cMyc, MyoD and Pax7
in SMs, ES cells and SiPS are given in Figure S1. (C) Chemical structure of RG108 (D) Phase contrast and (E) fluorescent images of GFP expressing SiPS
clones generated by RG108 (500 mM). (F) Graph showing generation of approximately 57–60 GFP
+ clones from 50,000 SMs 2–3 weeks after RG108
treatment. The control SMs were either without treatment or treated with DMSO (the solvent for RG108). Similar results were obtained in three
independent experiments. (G) DNA methylation analysis showing significant inhibition of DNA methyltransferase activity in SiPS cells in comparison
to the untreated SMs. Positive control shown in the graph was provided with the assay kit.
doi:10.1371/journal.pone.0023667.g001
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Harvard Apparatus, MA, USA). Body temperature was carefully
monitored with a probe (Cole-Parmer Instrument, IL, USA) and
was maintained at 37uC throughout the surgical procedure. The
heart was exposed by left-sided limited thoracotomy and the left
anterior descending (LAD) coronary artery was ligated with a
prolene #9-0 suture. Myocardial ischemia was confirmed by color
change of the left ventricular wall. The animals were grouped
(n=12 per group) for intramyocardial injection of 10 mL of basal
DMEM without cells (group-1) or containing 3610
5 SiPS (group-
2) or 3610
5 SiPS-CPs (group-3). The cells were injected
10 minutes after coronary artery ligation at multiple sites (3–4
sites per heart) in the free wall of the left ventricle under direct
vision. For post-engraftment tracking of the transplanted cells and
determination of their fate, the cells were labeled with PKH26
(Sigma, Product# PKH26-GL) according to manufacturer’s
instructions. The chest was closed and the animals were allowed
to recover. To alleviate pain, Buprinex (0.05 ml) was injected
subcutaneously in first 24 hours of surgery. The animals were
euthanized on 7 days and 4 weeks after transthoracic echocardi-
ography (as detailed in Text S1) for the heart function evaluation.
The hearts were frozen or fixed with 10% formalin solution and
processed for embedding in paraffin for immunohistological
studies.
Transthoracic Echocardiography
The animals (n=8 per group) were anesthetized and lightly
secured in the supine position on a warm pad. After the chest was
shaven, Acoustic gel was applied and transthoracic echocardiog-
raphy was performed using HDI-5000 SONOS-CT (HP)
ultrasound machine with a 7-MHz transducer. The heart was
imaged in the two-dimensional mode in the parasternal long-axis
and/or parasternal short-axis views which were subsequently used
to position the M-mode cursor perpendicular to the ventricular
septum and left ventricle posterior wall, after which M-mode
images were obtained. For each animal, measurements were
obtained from 4–5 consecutive heart cycles. Measurements of
ventricular septal thickness (VST), left ventricle internal dimension
(LVID), and left ventricle posterior wall thickness (LVPW) were
made from two-dimensionally directed M-mode images of the left
ventricle in both systole and diastole. The average value from all
measurements in an animal were used to determine the indices of
Figure 2. Characterization of SiPS for the expression of pluripotency markers. (A) Phase-contrast images of SiPS clones from RG108
treatment. Representative photomicrographs showing (a) untreated SMs on day 0 and (b) untreated SMs on day 15 showing fibroblast-like
morphology (c–f) Phase-contrast and GFP fluorescent images (green fluorescence) of SiPS clones 15 days after RG108 treatment (B) SiPS clones
stained for alkaline phosphatase activity. (C) SiPS clone showing normal karyotyping. (D) Immunostaining of SiPS ZP clone-1 expressing ES cell
specific markers Oct3/4, Sox2 and SSEA-1 (red fluorescence) and endogenous Oct4 (green fluorescence). Nuclei were stained with DAPI (blue
fluorescence). (E) RT-PCR analyses showing the endogenous gene expression of Nestin, Nanog, Rex-1, and Tert in SMs, ES and SiPS cells.
doi:10.1371/journal.pone.0023667.g002
Figure 3. Teratoma formation by SiPS upon transplantation in an immunodeficient mice. (A) Teratoma formation in nude mice (n=3) at 2
weeks after SiPS transplantation. (B) Histochemical staining for neural epithelium, cartilage, endodermal epithelium and smooth muscle (C)
Immunohistochemical studies for a–fetoprotein, desmin, and b-tubulin, to characterize teratoma from nude mice for differentiation into three germ
layers.
doi:10.1371/journal.pone.0023667.g003
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shortening (LVFS) and left ventricle ejection fraction (LVEF) using
the following relations LVFS=(LVEDd2LVESd)/LVEDd6100
and LVEF=[(LVEDd
32LVESd
3)/LVEDd
3]6100 and expressed
as percentages.
Results
Reprogramming of SMs with DNMT inhibitor
Mouse SMs were characterized for purity for desmin expression
by desmin immunostaining and flow cytometry which revealed
Figure 4. Embryoid bodies formation and beating pattern of murine ES cells and SiPS. (A) Phase contrast images showing the comparable
growth characteristics of undifferentiated (a) ES cells and (b) SiPS. Three days old embryoid bodies (EBs) derived from (c) ES cells and (d) SiPS. (B)
Spontaneously beating EBs from the ES and SiPS over time. Data are mean 6SEM.
doi:10.1371/journal.pone.0023667.g004
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endogenously expressed myogenic markers MyoD and Pax7 and 3
out of 4 pluripotency markers, Sox2, Klf4, cMyc as compared to
ES cells (Figure 1B). SMs were treated with DNMT inhibitor,
RG108 (Figure 1C). The successful reprogramming of SMs was
evident from their ES cell-like morphology and Oct4 driven GFP
Figure 5. In vitro cardiomyogenic differentiation of SiPS. SiPS were cultured in suspension for 3 days culture. (A) RT-PCR analysis of 5 days old
spontaneously beating EBs for cardiomyocyte specific markers, Gata4, Mef2c, Nkx2.5, and a-MHC., in comparison with SMs, undifferentiated SiPS and
ES cells. Mouse heart was used as positive control. Quantitative mRNA expression of Gata4, Mef2c, Nkx2.5, and a-MHC in SMs, mouse heart, SiPS, 5
days EBs and ES cells are shown in Figure S2. (B) Immunostaining of cardiac specific genes in 5 days EBs cells which were positive for cardiac specific
antigens Gata4, Nkx2.5 and Mef2c (merged images with DAPI). These cells were also positive for myosin heavy chain and expressed N-cadherin (red
fluorescence). (C–D) Ultra-structural features of SiPS-CPs in vitro. Transmission electron micrographs of SiPS-CPs showing typical striated sarcomeres
(s) with z-lines (z), nucleus (N) and mitochondria (M) (original magnifications; A=500006; B=600006).
doi:10.1371/journal.pone.0023667.g005
Figure 6. miR expression profile in SMs, SiPS and ES cells. (A) Heat map image of microarray showing miR expression profile in ES cells, and
SiPS which was quite different from SMs. Red fluorescence indicates the increased expression and green fluorescence indicates decreased expression
of miRs during reprogramming of SMs to SiPS. (B–D) Critical miRs known for reprogramming and differentiation of stem cells as observed in SMs, ES
cells and SiPS.
doi:10.1371/journal.pone.0023667.g006
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This treatment resulted in formation of 57 GFP
+ SiPS colonies per
50610
3 cells within two weeks (Figure 1F). On the other hand, no
colonies were formed in control SMs treated with DMSO (solvent
for RG108) or without RG108 treatment. DNA methylation
analysis showed that RG108 significantly reduced the DNMT
activity in SiPS as compared to the native SMs. A positive control
was provided with the kit (Figure 1G).
Characterization of SiPS generated with DNMT inhibitor
Culture of the undifferentiated SiPS on MEF or on gelatin
coated dishes without feeder layers exhibited a typical ES-cell like
morphology which appeared as compact, opaque, round clusters
with well-defined margins in undifferentiated state and expressed
Oct3/4 promoter driven GFP (Figure 2A). In comparison to SiPS,
native SMs retained their morphological characteristics after 20
days as elongated spindle shape and didn’t express Oct3/4
promoter driven GFP thus indicating their non-transformed status
(Figure 2A, b). The undifferentiated SiPS were positive for alkaline
phosphatase activity (Figure 2B) and had normal karyotypes
(Figure 2C) for more than 25 passages. Fluorescence immuno-
staining showed that DNMT inhibitor successfully reprogrammed
SMs to pluripotent status and induced ES cell specific markers
including endogenous Oct3/4, Sox2, and SSEA-1 (Figure 2D).
Figure 7. Histological evaluation of SiPS-CPs transplanted in the infarcted heart. (A–D) Microscopic images from recipient mouse hearts 4
weeks post-transplantation. The surviving 5 days EBs derived cardiac progenitors are identified by PKH26 (red fluorescence). The same area was
stained for myosin heavy chain (green fluorescence) and the nuclei were stained with DAPI (blue fluorescence). The superimposed photo-images
identified myosin as yellow in the merged images (A–D). The transplanted PKH26 labeled cardiac progenitors (yellow fluorescence) made contact
with the host myocardium (green fluorescence) through gap junctions (white), a component of intercalated disks, as indicated by red arrows.
(original magnifications: A=106,B=2 0 6,C&D=4 0 6).
doi:10.1371/journal.pone.0023667.g007
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SiPS expressed pluripotency markers Oct3/4, Sox2, Klf4, and
cMyc unlike native SMs which only expressed Sox2, Klf4, and
cMyc markers (Figure 1B). Additionally, SiPS also expressed
Nestin, Nanog, Rex1, Tert similar to ES cells (Figure 2E). These
data indicated that SiPS have primitive gene expression profile
similar to the ES cells. Subcutaneously injected SiPS formed
teratomas in immunodeficient mice (n=3) which showed typical
three germ layer characteristics (Figure 3).
In vitro differentiation of SiPS into spontaneously
contracting cardiac progenitors
The SiPS colonies derived from ZP clone-1 clone were
propagated in an undifferentiated state on MEF feeder layer
(Figure 4A). For in vitro cardiomyogenesis, SiPS cells were removed
from MEF feeder and cultured in suspension, where these cells
formed 3 dimensional differentiating cell aggregates (EBs) similar
to ES cells (Figure 4A). After 3 days in suspension, EBs were
seeded on gelatin-coated plates. Typical spontaneously contracting
EBs derived SiPS-CPs first appeared as early as 5 days (Video S1)
and the proportion of spontaneously contracting EBs increased up
to 15% in 2 weeks (Figure 4B) and continued to beat robustly for
3–4 weeks in culture.
Molecular characterization and immunostaining of SiPS
derived cardiac progenitors
We analyzed the 5 day beating EBs derived cardiac progenitors
for cardiac specific markers in comparison to native SMs,
undifferentiated SiPS and ES cells using mouse heart as a positive
control.Theexpression ofa seriesofcardiacmarkergenesincluding
Gata4, Nkx2.5, Mef2c, and a-MHC was significantly increased at 5
days of differentiation (Figure 5A). Contrarily, no expression of
these markers was observed in undifferentiated SiPS and ES cells.
SiPS-CPs were positively immunostained for Gata4, Nkx2.5,
Mef2c, N-cadherin and a-MHC (Figure 5B). Transmission electron
microscopy revealed ultra-structural features of 5 days beating EBs
with fully developed sarcomeres or myofilaments (Figure 5C–D).
MicroRNA microarray analysis
Microarray analyses showed similar global gene expression
profiles among SiPs and ES cells, which were very different from
that of SMs (Figure 6A–D).
In vivo transplantation of SiPS and SiPS-CPs
We directly injected SiPS and 5 days beating EBS derived
cardiac progenitors in the infarcted areas of left ventricle. We
observed extensive survival, proliferation and differentiation of
PKH26 labeled cardiac progenitors 4 weeks after transplantation
in the infarcted region (Figure 7A–C). No tumor formation was
observed in all the transplanted animals. Extensive myofibers were
formed in the infarcted area. Co-localization of PKH26 (red
fluorescence) with myosin heavy chain (green fluorescence) in the
infarct and peri-infarct regions in the SiPS-CPs transplanted
animal hearts indicated their myogenic differentiation (Figure 7A–
D) Furthermore these transplanted SiPS-CPs made junctions with
resident cardiomyocytes (Figure 7D).
Left ventricular remodeling and cardiac function
Four weeks after respective treatments, we performed histo-
chemical studies on at least two middle slices of the heart (n=6
per group). Masson trichrome staining showed that SiPS-CPs
treated animals had significantly reduced fibrosis as compared to
DMEM injected controls (21.1862.91% vs. 46.2363.1%,
p,0.01) and SiPS treated (37.3561.7) (Figure 8A–B). The
temporal changes in global heart function (Figure 8C) including
left ventricle ejection fraction (LVEF) and left ventricle fractional
shortening (LVFS) were measured as compared to the baseline
values (n=4; 78.162.8; 38.561.2% respectively). Transplanta-
tion of SiPS-CPs significantly improved LVEF and LVFS
(58.963; 26.562.9) in comparison with the DMEM treated
controls (32.6162.35%; 13.0662.2 p,0.05) and SiPS transplant-
ed hearts (44.3662.7; 18.6662.52) respectively. The pathological
remodeling of left ventricle in SiPS-CPs transplanted groups was
also significantly reduced as shown by left ventricle chamber
dimensions during systole (LVDs) and diastole (LVDd)
(2.9060.17 and 3.7560.1) in comparison with DMEM
(3.6360.2 and 4.5560.3) and SiPS treated group (3.2560.21
and 4.1160.25) respectively (Figure 8C).
Discussion
Given the moral and ethical difficulties associated with the use
of ES cells for transplantation, the novel approach to reprogram
Figure 8. SiPS-CPs improved cardiac function and reduced
infarction size 4 weeks post transplantation. (A) After 4 weeks of
therapy, Masson’s trichrome staining demonstrated reduced fibrosis
(blue staining) in hearts treated with SiPS-CPs as compared with DMEM
and SiPS. (B) Infarct size in various animal groups at 4 weeks after their
respective treatment. (C) Assessment of cardiac function. Left ventricle
ejection fraction (LVEF) and left ventricle fractional shortening (LVFS)
showed significant improvement in the hearts treated with SiPS-CPs as
compared to DMEM treated group and SiPS transplanted group. All
values were expressed as mean6 SEM.
* p,0.05 vs. control group; (n=6
per group).
doi:10.1371/journal.pone.0023667.g008
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tool for creating substitute cells with greater therapeutic potentials.
The use of retroviral vectors for induction of Yamanakas’ quartet
of transcription factors for iPS cell generation poses a serious risk
of tumorgenesis due to their integration into the host genome [1].
This can be circumvented by the use of non integrating vectors
either alone or in combination with small molecules. Small
molecules have been used to modify chromatin structure and
activate genes that are critical for restoring pluripotency. We
hypothesized that somatic cells with endogenous expression of one
or more stemness factors can make good candidates for
reprogramming. In this regard, SMs which endogenously express
three of the Yamanaks’s quartet of stemness factors are therefore
important candidates to generate iPS cells by induction of Oct3/4
expression which is lacking in SMs. We report here, for the first
time, that small molecule RG108, an inhibitor of DNMT, was
sufficient to reprogram mouse SMs to pluripotency with greater
efficiency and convenience. The significant findings of this study
are: (a) SMs can be reprogrammed to pluripotent status with
higher efficiency and the reprogrammed SMs exhibited morpho-
logical, molecular, and functional properties similar to the ES cells.
(b) Development and optimization of virus free strategy for
generation of iPS cells with small molecule treatment of SMs
which involved DNA methyltransferase inhibition. (c) Undifferen-
tiated SiPS cells are tumorgenic in immunodeficient hosts (d)
‘‘Directed’’ spontaneous cardiac differentiation of SiPS which
expressed cardiac-specific transcription factors and structural
proteins and showed synchronous beating activity in vitro. (e) SiPS
expressed ES cell like microRNA expression profile during
reprogramming. (f) Pre-differentiation of SiPS into cardiac
progenitor cells was ideal for tumor-free regeneration of infarcted
myocardium.
Inclusion of small molecules in the reprogramming protocols is
effective strategy to improve the efficiency of somatic cell
reprogramming. However, our protocol which solely involved
treatment of the cells with small molecules for induction of Oct3/4
for their efficient reprogramming to pluripotency is an important
new development [16–18]. SMs possess inherent myogenic
potential and are a good candidate for pluripotency due to
intrinsic expression of three of the four pluripotency determinant
transcription factors. Moreover, SMs have been extensively
studied for myocardial repair in both experimental animal models
and human patients [19–21]. Nevertheless, their lack of functional
integration post-engraftment in the heart and the incidence of
arrhythmia have limited their clinical applicability. It is highly
likely that the reprogrammed SMs would provide a superior
source of cardiac lineage cells for the repair of cardiovascular
diseases.
In vitro reprogramming is a very slow and inefficient process and
is associated with unforeseen risks such as subtle genetic and
epigenetic abnormalities in iPS cells. Histone acetylation and
methylation are important to the epigenetic status of the cells and
regulate the accessibility of the transcription machinery to the
DNA. Inhibition of histone deacetylase or DNA methyltransferase
with the use of epigenetic modifiers such as valproic acid and
azacytidine, alters chromatin remodeling and increases the
efficiency of standardized reprogramming protocols [22,11].
Various combinations of reprogramming factors with concomitant
small molecule treatment have been used for reprogramming of
somatic cells to yield better quality iPS cells with more efficiency
[23,24]. Consequently, it is highly desirable to identify new
conditions/small molecules that can promote reprogramming
and/or replace certain factors. In a recent study, SMs were
reprogrammed using retroviral vectors which showed that Oct3/4
induction was associated with MYoD suppression [25]. This is in
agreement with our findings that during reprogramming with
RG108, SMs lost the myogenic specific genes. Our study is the
first to show that somatic cells can be efficiently reprogrammed
with single small molecule without genetic modification using
exogenous stemness gene encoding viral vectors.
The present study highlights the unique advantage of complete
chemical approach for reprogramming that may ultimately allow
the generation of iPS cells in defined conditions without
permanent genetic modification. Our data provide a solid
foundation for developing regenerative medical therapies, includ-
ing availability of alternate sources for autologous cardiac stem
cells, and patient specific generation of iPS cell lines for the study
of rare diseases. However, a number of issues still need to be
addressed that include a complete understanding of expression of
pluripotency genes in different somatic cells without non-viral
approach and minimum transcriptional involvement with maxi-
mum reprogramming efficiency.
Besides improved efficiency of reprogramming, another signif-
icant finding of this study was spontaneous development of cardiac
like cells in vitro which showed synchronous beating activity. RT-
PCR and fluorescence immunostaining confirmed that these cells
expressed cardiac-specific transcription factors and proteins.
Although several studies have shown that iPS cells possess ES
cell like characteristics, very few have shown their application for
cardiac regeneration. The age of beating EBs is important for
selection of myocytes for transplantation. We discovered that
differentiating myocytes from older EBS derived cardiac progen-
itors were not as effective as the ones from 5 days old EBs (Data
not shown). Therefore, we opted to transplant cardiac progenitors
from 5 days beating EBs in this study. We not only observed
extensive myogenesis in SiPS-CPs transplanted hearts but also
these neomyocytes formed gap junctions with juxtaposed resident
cardiomyocytes. With the precise removal of EBs having minimal
contamination from undifferentiated SiPS for transplantation, no
tumorgenesis was observed in the animal hearts treated with SiPS-
CPs. Nevertheless, development of methods to enhance the purity
of SiPS-CPs preparation for transplantation combined with our
chemical method of reprogramming would be important in
curtailing tumorgenic nature of iPS cells [26–27] with efficient
cardiomyogenic differentiation potential.
We also observed that SiPS resembled ES cells in their miR
expression profile thus suggesting their regulatory control over the
fundamental processes including cell proliferation, cell differenti-
ation, cell survival and cellular responses to the environment [28–
29]. Significant changes were noted in the expression pattern of
let-7 family, miR-200 and miR-290 family in SiPS in comparison
with the native SMs. The let-7 family and miR-200 family were
downregulated in SiPS as compared to SMs which was similar to
ES cells indicated that SiPS were completely reprogrammed with
small molecule treatment. Additionally, the importance of
significant changes in expression of miRs including miR-21,
miR-23 and miR-26 observed during the course of this study
needs to be further investigated.
In summary, SMs with endogenous Sox2, Klf4, and cMyc are
excellent candidates to generate iPS cells by upregulation of only
Oct3/4 with the use of DNMT inhibitor. RG108 treatment of SMs
not only upregulated Oct3/4 but also increased the expression of
other already present factors. Reprogramming of SMs by RG108 is a
simple, highly reproducible, safer and efficient technique more likely
to regenerate patient specific cardiac progenitors for the treatment of
cardiovascular disease. Future studies however would be required to
determine the versatility of RG108 treatment and observe that our
small molecule treatment approach would be efficient
Non-Viral Generation of iPS Cells
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